Home Healthcare Biotechnology Antimicrobial Resistance Diagnostics Market

Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microbial Culture, Immunoassay, Polymerase Chain Reaction, Next-generation Sequencing, Mass Spectrometry, Others), By Pathogen (Methicillin-Resistant Staphylococcus Aureus, Drug-Resistant Streptococcus Pneumoniae, Drug-Resistant Campylobacter, Drug-Resistant Neisseria Gonorrhea, Drug-Resistant Salmonella, Others), By End Use (Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: January 13, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Antimicrobial Resistance Diagnostics Market Size Analysis
    1. Introduction
    2. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Microbial Culture
      2. Immunoassay
      3. Polymerase Chain Reaction
      4. Next-generation Sequencing
      5. Mass Spectrometry
      6. Others
    3. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. Methicillin-Resistant Staphylococcus Aureus 
      2. Drug-Resistant Streptococcus Pneumoniae
      3. Drug-Resistant Campylobacter
      4. Drug-Resistant Neisseria Gonorrhea
      5. Drug-Resistant Salmonella
      6. Others
    4. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
  7. North America Antimicrobial Resistance Diagnostics Market Size Analysis
    1. Introduction
    2. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Microbial Culture
      2. Immunoassay
      3. Polymerase Chain Reaction
      4. Next-generation Sequencing
      5. Mass Spectrometry
      6. Others
    3. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. Methicillin-Resistant Staphylococcus Aureus 
      2. Drug-Resistant Streptococcus Pneumoniae
      3. Drug-Resistant Campylobacter
      4. Drug-Resistant Neisseria Gonorrhea
      5. Drug-Resistant Salmonella
      6. Others
    4. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
  8. Europe Antimicrobial Resistance Diagnostics Market Size Analysis
    1. Introduction
    2. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Microbial Culture
      2. Immunoassay
      3. Polymerase Chain Reaction
      4. Next-generation Sequencing
      5. Mass Spectrometry
      6. Others
    3. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. Methicillin-Resistant Staphylococcus Aureus 
      2. Drug-Resistant Streptococcus Pneumoniae
      3. Drug-Resistant Campylobacter
      4. Drug-Resistant Neisseria Gonorrhea
      5. Drug-Resistant Salmonella
      6. Others
    4. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
  9. APAC Antimicrobial Resistance Diagnostics Market Size Analysis
    1. Introduction
    2. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Microbial Culture
      2. Immunoassay
      3. Polymerase Chain Reaction
      4. Next-generation Sequencing
      5. Mass Spectrometry
      6. Others
    3. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. Methicillin-Resistant Staphylococcus Aureus 
      2. Drug-Resistant Streptococcus Pneumoniae
      3. Drug-Resistant Campylobacter
      4. Drug-Resistant Neisseria Gonorrhea
      5. Drug-Resistant Salmonella
      6. Others
    4. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
  10. Middle East and Africa Antimicrobial Resistance Diagnostics Market Size Analysis
    1. Introduction
    2. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Microbial Culture
      2. Immunoassay
      3. Polymerase Chain Reaction
      4. Next-generation Sequencing
      5. Mass Spectrometry
      6. Others
    3. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. Methicillin-Resistant Staphylococcus Aureus 
      2. Drug-Resistant Streptococcus Pneumoniae
      3. Drug-Resistant Campylobacter
      4. Drug-Resistant Neisseria Gonorrhea
      5. Drug-Resistant Salmonella
      6. Others
    4. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
  11. LATAM Antimicrobial Resistance Diagnostics Market Size Analysis
    1. Introduction
    2. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Microbial Culture
      2. Immunoassay
      3. Polymerase Chain Reaction
      4. Next-generation Sequencing
      5. Mass Spectrometry
      6. Others
    3. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
      1. Methicillin-Resistant Staphylococcus Aureus 
      2. Drug-Resistant Streptococcus Pneumoniae
      3. Drug-Resistant Campylobacter
      4. Drug-Resistant Neisseria Gonorrhea
      5. Drug-Resistant Salmonella
      6. Others
    4. Antimicrobial Resistance Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Pharmaceutical & Biotechnology Companies
      4. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      3. Market Size & Forecast By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
  12. Competitive Landscape
    1. Antimicrobial Resistance Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. bioMérieux SA
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Hoffmann-La Roche AG
    3. Thermo Fisher Scientific Inc.
    4. Abbott
    5. Danaher
    6. BD
    7. QIAGEN N.V.
    8. Sysmex Corporation
    9. Bio-Rad Laboratories Inc.
    10. Accelerate Diagnostics Inc.
    11. Alifax S.r.l.
    12. Lumos Diagnostics Holdings Pty Ltd
    13. Molsid SAS
    14. Genetic Signatures Limited
    15. iFAST Diagnostics Ltd
    16. Astek Diagnostics Inc.
    17. OpGen Inc.
    18. T2 Biosystems, Inc.
    19. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.